The Fly | ALPMY

Today

Pfizer, Astellas announces FDA approval of PADCEV plus Keytruda in MIBC

11:26 AM

FDA approves Keytruda combos for certain muscle invasive bladder cancer cases

10:25 AM

Over a week ago

PeptiDream appoints three new executive vice presidents

Jul 2, 8:08 AM

Astellas, Pfizer announce FDA grants priority review to PADCEV, Keytruda sBLA

Apr 20, 6:48 AM

Vir Biotechnology closes global collaboration agreement with Astellas Pharma

Apr 16, 8:18 AM

Astellas Pharma exercises option to license capsid from Dyno Therapeutics

ALPMY

Apr 8, 8:13 AM

Pfizer, Astellas announce results from Phase 3 EV-304 trial for PADCEV

Feb 27, 10:06 AM

Astellas, Vir announce global strategic collaboration

Feb 23, 5:01 PM

Sanofi prepping higher bid for Ocular Therapeutix, IBD reports

Jan 15, 11:02 AM

Astellas, Pfizer report Padcev trial meets primary and secondary endpoints

Dec 17, 6:51 AM

Pfizer says FDA approves Padcev-Keytruda combo for certain patients

Nov 21, 1:25 PM

Astellas reports preliminary data from OPTION-VMS Phase IV study

ALPMY

Oct 22, 8:05 AM

Astellas Pharma says Padcev-Keytruda combo granted FDDA priority review

ALPMY

Oct 21, 7:39 PM

Astellas Pharma announces results from Phase 3 GATHER2 study

ALPMY

Oct 19, 9:17 PM

Astellas, Pfizer announces results from Phase 3 EV-303 trial for PADCEV

Oct 19, 5:15 PM

Taysha Gene Therapies regains full rights to TSHA-102 program

Oct 16, 4:08 PM

Astellas Pharma Chief Digital & Transformation Officer to leave on September 30

ALPMY

Sep 29, 6:23 AM

Bristol Myers commitment a reminder of Veeva's progress, says Stifel

Sep 22, 2:37 PM

Astellas Pharma just downgraded at Bernstein, here's why

ALPMY

Sep 2, 6:09 AM

Merck announces topline results from KEYNOTE-905 trial

Aug 12, 5:39 AM

Pfizer, Astellas Pharma announce topline results from EV-303 clinical trial

Aug 12, 5:36 AM

Astellas Pharma enters MOU with KISED for pact with Global Companies Program

ALPMY

Jul 17, 5:15 AM

No more stories